Eskisehir Osmangazi University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sep 12, 2026

Completed

Effect of Saccharomyces Boulardii CNCM I-745 on Antibiotic-perturbed Microbiota in Children: RESTORE STUDY

Sep 12, 2026

Recruiting

A Multicenter, Prospective, Randomized, Double-Blind, Open-Label Clinical Trial Evaluating the Effects of Lacticaseibacillus Rhamnosus GG on Acute Infectious Diarrhea in Children in Türkiye

Earlier

Aug 22, 2026TrialThe Effectiveness of an Artificial Intelligence-Generated, Patient-Specific Storybook for Behaviour Guidance: A Randomized Controlled Trial

Aug 22, 2026TrialRespiratory Variation of Internal Jugular Vein Diameter as a Novel Ultrasonographic Marker of Disease Severity in Infants With Acute Bronchiolitis: A Prospective Observational Cohort Study

Aug 13, 2026TrialComparison of Single-Needle Arthrocentesis and Intravenous Catheter-Assisted Arthrocentesis in the Management of Temporomandibular Joint Disorders

Aug 7, 2026TrialThe Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees: A Randomized Controlled Trial

Jul 30, 2026TrialThe Effect of Cognitive Behavioral Psychoeducation on Internalized Stigma in Individuals With Bipolar Disorder: A Randomized Controlled Trial

Jul 18, 2026TrialEffect of Titanium-Prepared Platelet-Rich Fibrin on Extraction Socket Healing: A Randomized Clinical Trial Using CBCT-Based Volumetric Analysis

4 more events

Jul 2, 2026TrialEXAMINING THE EFFECT OF A GROUP-BASED STRESS MANAGEMENT COURSE ON EMPOWERING THE MENTAL HEALTH OF MEDICAL FACULTY STUDENTS AND RESIDENT PHYSICIANS: A RANDOMIZED CONTROLLED STUDY

Sep 28, 2022TrialThe Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex

Mar 1, 2022TrialClinical Efficacy of Exosome in Degenerative Meniscal Injury

Jun 1, 2019TrialHand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)